Quest Diagnostics
DGX
#1090
Rank
โ‚น1.500 T
Marketcap
โ‚น13,448
Share price
2.03%
Change (1 day)
21.55%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น774.10 Billion

According to Quest Diagnostics 's latest financial reports the company's total liabilities are โ‚น774.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Quest Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น633.02 B12%
2022-12-31โ‚น565.18 B7.72%
2021-12-31โ‚น524.66 B0.55%
2020-12-31โ‚น521.81 B3.35%
2019-12-31โ‚น504.88 B27.59%
2018-12-31โ‚น395.69 B13.33%
2017-12-31โ‚น349.13 B-4.2%
2016-12-31โ‚น364.44 B5.89%
2015-12-31โ‚น344.17 B-1.75%
2014-12-31โ‚น350.29 B13.97%
2013-12-31โ‚น307.35 B10.11%
2012-12-31โ‚น279.13 B-5.75%
2011-12-31โ‚น296.15 B47.74%
2010-12-31โ‚น200.45 B-5.1%
2009-12-31โ‚น211.22 B-8.43%
2008-12-31โ‚น230.66 B12.13%
2007-12-31โ‚น205.70 B75.77%
2006-12-31โ‚น117.02 B2.26%
2005-12-31โ‚น114.44 B37.98%
2004-12-31โ‚น82.94 B-4.46%
2003-12-31โ‚น86.81 B16.39%
2002-12-31โ‚น74.58 B-3.06%
2001-12-31โ‚น76.94 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น879.83 B 13.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.36 B-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น61.37 B-92.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.50 B-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น183.89 B-76.24%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands